Capstone Investment Advisors’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Capstone Investment Advisors's EXAS Position: Q1 2026 in Review
Capstone Investment Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 251,384 shares — an estimated $25.5M sold.
Capstone Investment Advisors first reported a position in EXAS in Q2 2017 and held it in 9 quarters. The position peaked at $25.5M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Capstone Investment Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Capstone Investment Advisors sold 251,384 Exact Sciences shares in Q1 2026, an estimated $25.5M.
- Capstone Investment Advisors first reported a position in Exact Sciences in Q2 2017 and held it in 9 quarters.
- Capstone Investment Advisors's Exact Sciences position peaked at $25.5M in Q4 2025.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.